IHS Chemical Week

World News and Views :: Top of the News

Mitsubishi Tanabe Pharma to acquire Canadian biopharma company Medicago

9:22 AM MDT | July 15, 2013 | Natasha Alperowicz

Medicago (Quebec City, PQ), a biopharmaceutical company focused on developing vaccines based on proprietary manufacturing technologies, announced on Friday that it has entered into a definitive agreement with Mitsubishi Tanabe Pharma Corp. (MTPC; Osaka) whereby MTPC will acquire all of the issued and outstanding common shares of Medicago, other than the shares currently held by Philip Morris Investments (PMI; Bergen on Zoom, Netherlands), an affiliate of Philip Morris International and MTPC, for $1.16/share in cash or a maximum of C$179 million ($172.2...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa